留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

实体器官移植术后隐球菌病的研究进展

陈莉萍

陈莉萍. 实体器官移植术后隐球菌病的研究进展[J]. 器官移植, 2018, 9(1): 9-15. doi: 10.3969/j.issn.1674-7445.2018.01.002
引用本文: 陈莉萍. 实体器官移植术后隐球菌病的研究进展[J]. 器官移植, 2018, 9(1): 9-15. doi: 10.3969/j.issn.1674-7445.2018.01.002
Chen Liping. Research progress of cryptococcosis after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(1): 9-15. doi: 10.3969/j.issn.1674-7445.2018.01.002
Citation: Chen Liping. Research progress of cryptococcosis after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(1): 9-15. doi: 10.3969/j.issn.1674-7445.2018.01.002

实体器官移植术后隐球菌病的研究进展

doi: 10.3969/j.issn.1674-7445.2018.01.002
基金项目: 

国家自然科学基金 B17770547

详细信息
    作者简介:

    陈莉萍,医学博士,副主任医师,硕士研究生导师,现工作于解放军第309医院全军器官移植研究所。研究方向为器官移植并发症与重症管理。兼任中国研究型医院学会糖尿病学专业委员会器官移植与代谢性疾病学组委员。兼任《器官移植》杂志通讯编委。主持国家自然科学基金等基金项目2项。获国家科技进步奖二等奖、军队科技进步二等奖及其它省部级奖项4项。2012年主持研发“中国肾移植科学登记系统”(www.csrkt.org),接收全国132家具有肾脏移植手术资质的医疗机构在线填报肾移植病例。以第一作者或通讯作者身份发表论著25篇,其中SCI论文4篇,参编《中国人体器官捐献工作指南(第5版)》、《泌尿外科常见急症应对措施》、《泌尿外科医师进修手册》、《泌尿外科疑难病例解析》等学术著作6部。Email: paradiselily@163.com

  • 中图分类号: R617, R379.5

Research progress of cryptococcosis after solid organ transplantation

  • 摘要: 隐球菌病是实体器官移植术后最主要的致死性真菌感染性疾病,大多数伴有中枢神经系统侵犯。由于临床症状缺乏特异性,可能导致延误诊断,预后不佳,而早期诊断和充分有效的抗真菌治疗是改善移植受体隐球菌病预后的主要策略。本文对隐球菌病的流行病学、发病机制、临床表现、诊断方法、防治措施,结合我国器官移植实际情况进行综述。

     

  • [1] NEOFYTOS D, FISHMAN JA, HORN D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients[J]. Transpl Infect Dis, 2010, 12(3): 220-229. DOI: 10.1111/j.1399-3062.2010.00492.x.
    [2] WANG H, XIAO M, CHEN SC, et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol, 2012, 50(12): 3952-3959. DOI: 10.1128/JCM.01130-12.
    [3] FANG W, FA Z, LIAO W. Epidemiology of cryptococcus and cryptococcosis in China[J]. Fungal Genet Biol, 2015, 78: 7-15. DOI: 10.1016/j.fgb.2014.10.017.
    [4] 陈敏, 潘炜华, 邓淑文, 等. 格特隐球菌感染病例临床特征分析[C]//2012年中国菌物学会学术年会论文集, 2012: 88.
    [5] XUE X, WU H, WANG K, et al. Cryptococcosis by cryptococcus gattii in China[J]. Lancet Infect Dis, 2015, 15(10): 1135-1136. DOI: 10.1016/S1473-3099(15)00301-1.
    [6] HENAO-MARTÍNEZ AF, BECKHAM JD. Cryptococcosis in solid organ transplant recipients[J]. Curr Opin Infect Dis, 2015, 28(4): 300-307. DOI: 10.1097/QCO.0000000000000171.
    [7] SINGH N, HUPRIKAR S, BURDETTE SD, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice[J]. Am J Transplant, 2012, 12(9): 2414-2428. DOI: 10.1111/j.1600-6143.2012.04100.x.
    [8] LIN YY, SHIAU S, FANG CT. Risk factors for invasive cryptococcus neoformans diseases: a case-control study[J]. PLoS One, 2015, 10(3): e0119090. DOI: 10.1371/journal.pone.0119090.
    [9] PERFECT JR, BICANIC T. Cryptococcosis diagnosis and treatment: what do we know now[J]. Fungal Genet Biol, 2015, 78: 49-54. DOI: 10.1016/j.fgb.2014.10.003.
    [10] SAHA DC, GOLDMAN DL, SHAO X, et al. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients[J]. Clin Vaccine Immunol, 2007, 14(12): 1550-1554. DOI: 10.1128/CVI.00242-07.
    [11] 邱天文, 朱红梅, 温海, 等.隐球菌侵袭血脑屏障相关机制研究进展[J].中国真菌学杂志, 2016, 11(3): 190-192, 189. DOI: 10.3969/j.issn.1673-3827.2016.03.016.

    QIU TW, ZHU HM, WEN H, et al. Progress in the study of related mechanisms of cryptococcal invasion of the blood brain barrier[J]. Chin J Mycol, 2016, 11(3): 190-192, 189. DOI: 10.3969/j.issn.1673-3827.2016.03.016.
    [12] YUCHONG C, FUBIN C, JIANGHAN C, et al. Cryptococcosis in China (1985-2010): review of cases from Chinese database[J]. Mycopathologia, 2012, 173(5/6): 329-335. DOI: 10.1007/s11046-011-9471-1.
    [13] OSAWA R, ALEXANDER BD, LORTHOLARY O, et al. Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis[J]. Transplantation, 2010, 89(1): 69-74. DOI: 10.1097/TP.0b013e3181bcda41.
    [14] YANG YL, CHEN M, GU JL, et al. Cryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published cases[J]. Int J Infect Dis, 2014, 26: 154-161. DOI: 10.1016/j.ijid.2014.05.028.
    [15] HUSAIN S, WAGENER MM, SINGH N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome[J]. Emerg Infect Dis, 2001, 7(3): 375-381. DOI: 10.3201/eid0703.010302.
    [16] SINGH N. How I treat cryptococcosis in organ transplant recipients[J]. Transplantation, 2012, 93(1): 17-21. DOI: 10.1097/TP.0b013e318236cd1a.
    [17] HUNG MS, TSAI YH, LEE CH, et al. Pulmonary cryptococcosis: clinical, radiographical and serological markers of dissemination[J]. Respirology, 2008, 13(2): 247-251. DOI: 10.1111/j.1440-1843.2007.01202.x.
    [18] SHOHAM S, MARR KA. Invasive fungal infections in solid organ transplant recipients[J]. Future Microbiol, 2012, 7(5): 639-655. DOI: 10.2217/fmb.12.28.
    [19] BIANCHERI D, KANITAKIS J, BIENVENU AL, et al. Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic features[J]. Eur J Dermatol, 2012, 22(5): 651-657. DOI: 10.1684/ejd.2012.1819.
    [20] DESHAYES S, BOUVIER N, CHATELET V, et al. Severe cryptococcal-associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab[J]. Transpl Infect Dis, 2016, 18(3): 461-465. DOI: 10.1111/tid.12522.
    [21] GUPTA AO, SINGH N. Immune reconstitution syndrome and fungal infections[J]. Curr Opin Infect Dis, 2011, 24(6): 527-533. DOI: 10.1097/QCO.0b013e32834ab20a.
    [22] LEGRIS T, MASSAD M, PURGUS R, et al. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient[J]. Transpl Infect Dis, 2011, 13(3): 303-308. DOI: 10.1111/j.1399-3062.2010.00592.x.
    [23] HENAO-MARTÍNEZ AF, BECKHAM JD. Cryptococcosis in solid organ transplant recipients[J]. Curr Opin Infect Dis, 2015, 28(4): 300-307. DOI: 10.1097/QCO.0000000000000171.
    [24] MAZIARZ EK, PERFECT JR. Cryptococcosis[J]. Infect Dis Clin North Am, 2016, 30(1): 179-206. DOI: 10.1016/j.idc.2015.10.006.
    [25] 季淑娟, 倪玲红, 张俊丽, 等.不同荚膜抗原检测方法对隐球菌脑膜脑炎诊断和疗效评估的价值[J].中华医学杂志, 2015, 95(46): 3733-3736. DOI: 10.3760/cma.j.issn.0376-2491.2015.46.003.

    JI SJ, NI LH, ZHANG JL, et al. Value of three capsular antigen detection methods in diagnosis and efficacy assessment in patients with cryptococcal meningoencephalitis[J]. Natl Med J China, 2015, 95(46): 3733-3736. DOI: 10.3760/cma.j.issn.0376-2491.2015.46.003.
    [26] JARVIS JN, HARRISON TS, LAWN SD, et al. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa[J]. PLoS One, 2013, 8(7): e69288. DOI: 10.1371/journal.pone.0069288.
    [27] KABANDA T, SIEDNER MJ, KLAUSNER JD, et al. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid[J]. Clin Infect Dis, 2014, 58(1): 113-116. DOI: 10.1093/cid/cit641.
    [28] SINGH N, LORTHOLARY O, DROMER F, et al. Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings[J]. Transplantation, 2008, 86(5): 647-651. DOI: 10.1097/TP.0b013e3181814e76.
    [29] 黄铭珊, 金霆.探讨实时荧光定量PCR法检测血液新生隐球菌的临床意义[J].实用检验医师杂志, 2015, 7(1): 28-31. DOI: 10.3969/j.issn.1674-7151.2015.01.008.

    HUANG MS, JIN T. The clinical value of RT-FQ-PCR method for cryptococcus neoformans detection in blood[J]. Chin J Lab Pathol, 2015, 7 (1): 28-31. DOI: 10.3969/j.issn.1674-7151.2015.01.008.
    [30] PAPPAS PG, ALEXANDER BD, ANDES DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Clin Infect Dis, 2010, 50(8): 1101-1111. DOI: 10.1086/651262.
    [31] PERFECT JR, DISMUKES WE, DROMER F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America[J]. Clin Infect Dis, 2010, 50(3): 291-322. DOI: 10.1086/649858.
    [32] BRATTON EW, EL HUSSEINI N, CHASTAIN CA, et al. Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis[J]. Antimicrob Agents Chemother, 2013, 57(6): 2485-2495. DOI: 10.1128/AAC.01800-12.
    [33] DAY JN, CHAU TTH, WOLBERS M, et al. Combination antifungal therapy for cryptococcal meningitis[J]. N Engl J Med, 2013, 368(14): 1291-1302. DOI: 10.1056/NEJMoa1110404.
    [34] SCEMLA A, GERBER S, DUQUESNE A, et al. Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient[J]. Am J Transplant, 2015, 15(2): 560-564. DOI: 10.1111/ajt.13002.
    [35] CHEN SC, KORMAN TM, SLAVIN MA, et al. Antifungal therapy and management of complications of cryptococcosis due to cryptococcus gattii[J]. Clin Infect Dis, 2013, 57(4): 543-551. DOI: 10.1093/cid/cit341.
    [36] LORTHOLARY O, FERNÁNDEZ-RUIZ M, PERFECT JR. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis)[J]. J Antimicrob Chemother, 2016, 71(suppl 2): ⅱ31-ⅱ36. DOI: 10.1093/jac/dkw394.
  • 加载中
计量
  • 文章访问数:  159
  • HTML全文浏览量:  54
  • PDF下载量:  19
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-10-24
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2018-01-15

目录

    /

    返回文章
    返回